Posts

U.S. Launches Section 301 Investigation into Germany Over Drug Pricing and Unfair R&D Burden in 2026

on
Sources: USTR Announces Initiation of Section 301 Investigation of ... Merz Expects US to Stand by Trade Pact After German Drug Probe Increasing Divergence in Drug Prices Between the United States ... U.S. opens tariff probe targeting Germany's drug pricing policies Washington, United States, June 19, 2026 (AFP) - US opens trade ... Drug Price Moderation in Germany: Lessons for U.S. Reform Efforts US Launches Tariff Probe Into Germany Over Pharma Pricing US launches Section 301 probe into Germany over drug pricing By Reuters US launches investigation into Germany's pharmaceutical pricing ... U.S. Launches Trade Probe Into Germany Over Drug Pricing United States of America: Initiation of Section 301 investigation into ... This Is What's at Stake if U.S. Drug Prices Fall — and Europeans ... The US has opened a trade investigation into Germany's ... - Facebook The US launched a fresh tariff investigation into Germany over what ... The US has l...

Moderna’s mRNA flu shot wins unanimous support at FDA adcomm in rebuke of former leadership

on

Shionogi Announces Supplemental Approval in Japan for Pediatric Dosage and Administration of XOCOVA to Treat COVID-19

on

cAMPfield Raises $180M to Bring PDE4 Inhibition to IBD

on

Portal Biotechnologies raises $9M for cell engineering tech that’s attracted Merck & Co., AbbVie

on

Novocure's bid to move electric fields therapy earlier in glioblastoma falls short

on

FDA panel strongly backs Moderna's mRNA flu vaccine for older adults, with final decision expected by early August 2026.

on

Chai Discovery Collaborates with Lilly TuneLab to Offer AI Capabilities to Select Biotechs

on

Friday Five: Verges neuro drug-to-data pivot

on

4 years after FDA snub, GSK partnership propels Spero’s Utebzi across approval finish line

on

Biogen acquires RayThera in up to $1B deal to bolster preclinical immunology pipeline

on

FDA Accepts sBLA for Roche's Lunsumio VELO and Polivy Combination in Relapsed or Refractory Large B-Cell Lymphoma

on

UPDATED: Kardigan buttons up $400M upsized IPO to power heart drugs toward phase 3

on